June 6, 2014
Impax Laboratories, Inc.
invites investors and the general public to listen to a webcast of a discussion with
, President and CEO, and
Bryan M. Reasons
, Chief Financial Officer, at the Goldman Sachs 35
Annual Global Healthcare Conference on
Thursday, June 12, 2014
8:40 a.m. Pacific Time
To listen to the live or archived webcast, visit the investor relations section of the Company's web site at
. This presentation will be archived on the Company's web site for 30 days.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. (Impax) is a technology based specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty generics in addition to the development of central nervous system disorder branded products. Impax markets its generic products through its Global Pharmaceuticals division and markets its branded products through the Impax Pharmaceuticals division. Additionally, where strategically appropriate, Impax develops marketing partnerships to fully leverage its technology platform and pursues partnership opportunities that offer alternative dosage form technologies, such as injectables, nasal sprays, inhalers, patches, creams and ointments. For more information, please visit the Company's Web site at:
Investor Relations and Corporate Communications (215) 558-4526
SOURCE Impax Laboratories, Inc.